Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease

NeuroImage

Volumn 26, Issue 4, 2005, Pages 1150-1158

  Andringa, Gerda ^a   Drukarch, Benjamin ^a   Bol, John G J M ^a   De Bruin, Kora ^b   Sorman, Karolina ^a   Habraken, Jan B A ^b   Booij, Jan ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Dopamine transporter; FP CIT; Immunohistochemistry; MPTP; Parkinson's disease; Pinhole SPECT

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE TRANSPORTER; IODINE 123;

ACCURACY; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; COCAINE; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; NEOSTRIATUM; NERVE TISSUE PROTEINS; PARKINSON DISEASE, SECONDARY; RADIOPHARMACEUTICALS; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 20444379646     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2005.03.034     Document Type: Article

References (57)

1. A. Abi-Dargham, M.S. Gandelman, G.A. DeErausquin, Y. Zea-Ponce, S.S. Zoghbi, R.M. Baldwin, M. Laruelle, D.S. Charney, P.B. Hoffer, J.L. Neumeyer, and R.B. Innis SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of β-CIT J. Nucl. Med. 37 1996 1129 1133
2. P.D. Acton, and H.F. Kung Small animal imaging with high resolution single photon emission tomography Nucl. Med. Biol. 30 2003 889 895
3. P.D. Acton, S.R. Choi, K. Plössl, and H.F. Kung Quantification of dopamine transporters in the mouse brain using ultra-high resolution single-photon emission tomography Eur. J. Nucl. Med. 29 2002 691 698
4. 123I]IBF Eur. J. Nucl. Med. 29 2002 1507 1515
5. 11C-raclopride binding in the rat brain measured with the microPET R4: effects of scatter correction and tracer specific activity J. Nucl. Med. 44 2003 815 822
6. G. Andringa, R.V. van Oosten, W. Unger, T.G. Hafmans, J. Veening, J.C. Stoof, and A.R. Cools Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra Eur. J. Neurosci. 12 2000 3033 3043
7. +-induced dopaminergic nigrostriatal injury in rat J. Neurochem. 80 2002 365 374
8. 123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys Synapse 27 1997 183 190
9. 123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease J. Neurol., Neurosurg. Psychiatry 62 1997 133 140
10. J. Booij, J.B. Habraken, P. Bergmans, G. Tissingh, A. Winogrodzka, E.C. Wolters, A.G. Janssen, J.C. Stoof, and E.A. van Royen Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease J. Nucl. Med. 39 1998 1879 1884
11. J. Booij, G. Tissingh, A. Winogrodzka, and E.A. van Royen Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism Eur. J. Nucl. Med. 26 1999 171 182
12. J. Booij, K. de Bruin, J.B. Habraken, and P. Voorn Imaging of dopamine transporters in rats using high-resolution pinhole single-photon emission tomography Eur. J. Nucl. Med. Mol. Imaging 29 2002 1221 1224
13. J. Booij, K. de Bruin, M.M. de Win, C. Lavini, G.J. den Heeten, and J.B. Habraken Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible Nucl. Med. Biol. 30 2003 643 649
14. + in the rat Neurosci. Lett. 118 1990 151 154
15. 18F]cyclofoxy and positron emission tomography J. Cereb. Blood Flow Metab. 13 1993 24 42
16. J. Chagkutip, R.A. Vaughan, P. Govitrapong, and M. Ebadi 1-Methyl-4-phenylpyridinium-induced down-regulation of dopamine transporter function correlates with a reduction in dopamine transporter cell surface expression Biochem. Biophys. Res. Commun. 311 2003 49 54
17. 125I]RTI-55 Brain Res. 690 1995 217 224
18. T. Dehmer, M.T. Heneka, M. Sastre, J. Dichgans, and J.B. Schulz Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation J. Neurochem. 88 2004 494 501
19. J. Delforge, M. Bottlaender, S. Pappata, C. Loc'h, and A. Syrota Absolute quantification by positron emission tomography of the endogenous ligand J. Cereb. Blood Flow Metab. 21 2001 613 630
20. J.L. Eberling, K.S. Bankiewicz, S. Jordan, H.F. VanBrocklin, and W.J. Jagust PET studies of functional compensation in a primate model of Parkinson's disease NeuroReport 8 1997 2727 2733
21. L. Farde, H. Hall, E. Ehrin, and G. Sedvall Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET Science 231 1986 258 261
22. L.A. Feldkamp, L.C. Davis, and J.W. Kress Practical cone-beam algorithm J. Opt. Soc. Am. 1 1984 612 619
23. J.B. Habraken, K. de Bruin, M. Shehata, J. Booij, R. Bennink, B.L. van Eck Smit, and E. Busemann Sokole Evaluation of high-resolution pinhole SPECT using a small rotating animal J. Nucl. Med. 42 2001 1863 1869
24. S.M. Hsu, L. Raine, and H. Fanger Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures J. Histochem. Cytochem. 29 1981 577 580
25. S.P. Hume, A.A. Lammertsma, R. Myers, S. Rajeswaran, P.M. Bloomfield, R. Ashworth, R.A. Fricker, E.M. Torres, I. Watson, and T. Jones The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease J. Neurosci. Methods 67 1996 103 112
26. S. Hume, D.J. Brown, S. Ashworth, E. Hirani, S. Luthra, and A.A. Lammertsma In vivo saturation of two dopamine transporter probes measured with a small positron emission tomography scanner J. Neurosci. Methods 76 1997 45 51
27. S.P. Hume, R.N. Gunn, and T. Jones Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals Eur. J. Nucl. Med. 25 1998 173 176
28. 11C]SA4503 binding was not by raclopride Nucl. Med. Biol. 28 2001 787 792
29. K. Ishizu, M.Y. Yonekura, M. Pagani, Y. Magata, S. Nishizawa, N. Tamaki, H. Shibasaki, and J. Konishi Ultra-high resolution SPECT system using four pinhole collimators for small animal studies J. Nucl. Med. 36 1995 2282 2287
30. V. Jackson-Lewis, M. Jakowec, R.E. Burke, and S. Przedborski Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurodegeneration 4 1995 257 269
31. M.W. Jakowec, K. Nixon, E. Hogg, T. McNeill, and G.M. Petzinger Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway J. Neurosci. Res. 76 2004 539 550
32. K.M. Kahlig, and A. Galli Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine Eur. J. Pharmacol. 479 2003 153 158
33. D. Kaur, F. Yantiri, S. Rajagopalan, J. Kumar, J.Q. Mo, R. Boonplueang, V. Viswanath, R. Jacobs, L. Yang, M.F. Beal, D. DiMonte, I. Volitaskis, L. Ellerby, R.A. Cherny, A.I. Bush, and J.K. Andersen Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease Neuron 37 2003 899 909
34. M.R. Kilbourn, K. Kuszpit, and P. Sherman Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice Synapse 35 2000 250 255
35. 123I]FP-CIT SPET in healthy volunteers Eur. J. Nucl. Med. 27 2000 867 869
36. G.W. Miller, J.K. Staley, C.J. Heilman, J.T. Perez, D.C. Mash, D.B. Rye, and A.I. Levey Immunochemical analysis of dopamine transporter protein in Parkinson's disease Ann. Neurol. 41 1997 530 539
37. R. Myers, and S. Hume Small animal PET Eur. Neuropsychopharmacol. 12 2002 545 555
38. 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals J. Nucl. Med. 44 2003 618 624
39. H. Olsson, C. Halldin, and L. Farde Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET NeuroImage 22 2004 794 803
40. M. Orth, and S.J. Tabrizi Models of Parkinson's disease Mov. Disord. 18 2003 729 737
41. E. Pileblad, H. Nissbrandt, and A. Carlsson Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (NMPTP) in mouse brain J. Neural Transm. 60 1984 199 203
42. S. Przedborski, and M. Vila The 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease Ann. N. Y. Acad. Sci. 991 2003 189 198
43. D.J. Rubins, A.K. Meadors, S. Yee, W.P. Melega, and S.R. Cherry Evaluation of a stereotactic frame for repositioning of the rat brain in serial positron emission tomography imaging studies J. Neurosci. Methods 107 2001 63 70
44. H. Saji, Y. Iida, H. Kawashima, M. Ogawa, Y. Kitamura, T. Mukai, S. Shimazu, and F. Yoneda In vivo imaging of brain dopaminergic neurotransmission system in small animals with high-resolution single photon emission computed tomography Anal. Sci. 19 2003 67 71
45. 123I]CIT pinhole SPECT NeuroImage 17 2002 128 141
46. L.C. Schmued, and K.J. Hopkins Fluoro-Jade: novel fluorochromes for detecting toxicant-induced neuronal degeneration Toxicol. Pathol. 28 2000 91 99
47. J.P. Seibyl, K. Marek, K. Sheff, S. Zoghbi, R.M. Baldwin, D.S. Charney, C.H. van Dyck, and R.B. Innis Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients J. Nucl. Med. 39 1998 1500 1508
48. A. Sohlberg, S. Lensu, J. Jolkkonen, L. Tuomisto, U. Ruotsalainen, and J.T. Kuikka Improving the quality of small animal brain pinhole SPECT imaging by Bayesian reconstruction Eur. J. Nucl. Med. Mol. Imaging 31 2004 986 994
49. W.P. Spooren, C. Gentsch, and C. Wiessner TUNEL-positive cells in the substantia nigra of C57BL/6 mice after a single bolus of 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine Neuroscience 85 1998 649 651
50. H. Turmel, A. Hartmann, K. Parain, A. Douhom, A. Srinivasan, Y. Agid, and E.C. Hirsch Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-treated mice Mov. Disord. 16 2001 185 189
51. N.J. Uretsky, and L.L. Iversen Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain J. Neurochem. 17 1970 269 278
52. P. Van der Zee, H.S. Koger, J. Gootjes, and W. Hespe Aryl 1,4-dialk(en)ylpiperazines as selective and very potent inhibitors of dopamine uptake Eur. J. Med. Chem. 15 1980 363 370
53. F.L. Van Muiswinkel, J.G. Bol, J.M. Ruijter, J.C. Stoof, B. Drukarch, and H.W. Steinbusch Repeated administration of a selective dopamine D2 receptor agonist to 6-OHDA-lesioned rats does not affect the survival and outgrowth of intrastriatal fetal mesencephalic grafts Exp. Brain Res. 107 1995 52 58
54. V. Viswanath, Y. Wu, R. Boonplueang, S. Chen, F.F. Stevenson, F. Yantiri, L. Yang, M.F. Beal, and J.K. Andersen Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Parkinson's disease Neuroscience 21 2001 9519 9528
55. N.D. Volkow, Y.S. Ding, J.S. Fowler, G.J. Wang, J. Logan, S.J. Gatley, R. Hitzemann, G. Smith, S.D. Fields, and R. Gur Dopamine transporters decrease with age J. Nucl. Med. 37 1996 554 559
56. M.C. Wu, H.R. Tang, D.W. Gao, A. Ido, O.W. O'Connell, B.H. Hasegawa, and M.W. Dae ECG-gated pinhole SPECT in mice with millimeter spatial resolution IEEE Trans. Nucl. Sci. 47 2000 1218 1227
57. W. Zhang, T. Wang, L. Qin, H.M. Gao, B. Wilson, S.F. Ali, W. Zhang, J.S. Hong, and B. Liu Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase FASEB J. 18 2004 589 591